Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
06/2005
06/30/2005US20050142322 Optical recording media and dipyrrpomethene-metal chelate compounds
06/30/2005DE10354629A1 2-Ethyl-4,6-dimethyl-phenyl substituierte spirocyclische Tetramsäure-Derivate 2-ethyl-4,6-dimethyl-phenyl substituted spirocyclic tetramic acid derivatives
06/30/2005CA2550886A1 Polymorphic forms of tegaserod base and salts thereof
06/30/2005CA2549825A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
06/30/2005CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof
06/30/2005CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
06/30/2005CA2549167A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease
06/30/2005CA2549072A1 Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease
06/29/2005EP1547603A2 Compositions and methods for use in targeting vascular destruction
06/29/2005EP1547590A1 Melanin extinguisher
06/29/2005EP1546371A1 Substrates for o6-alkylguanine-dna alkyltransferase
06/29/2005EP1546153A1 Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors
06/29/2005EP1546142A2 Indoles having anti-diabetic activity
06/29/2005EP1546116A1 Vanilloid receptor ligands and their use in treatments
06/29/2005EP1546108A1 1,4-substituted cyclohexane derivatives
06/29/2005EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
06/29/2005EP1546098A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
06/29/2005EP1546088A2 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
06/29/2005EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs
06/29/2005EP1545528A2 Indole-type derivatives as inhibitors of p38 kinase
06/29/2005EP1545510A1 Substituted phenylindoles for the treatment of hiv
06/29/2005EP1545508A1 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonist
06/29/2005EP1485352B1 Azaspiro compounds for the treatment of pain
06/29/2005EP1373272B1 Tert. alkylphenoxy substituted polycyclic compounds
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005EP1242069B1 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
06/29/2005EP0901459B1 Calcilytic compounds
06/29/2005CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/29/2005CN1631880A Carbazole dithioformate RAFT reagent and preparation method and application thereof
06/29/2005CN1631879A Substituted phenyl keto enols as pesticides and herbicides
06/29/2005CN1631878A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
06/29/2005CN1208333C Indole derivatives useful for the treatment of osteoporosis
06/29/2005CN1208329C Aniline derivatives
06/29/2005CN1208322C Dihydroindole and tetrahydroquinoline derivatives
06/28/2005US6911468 Useful as a prophylactic or therapeutic agent for diabetes or the like
06/28/2005US6911465 For treating inflammatory diseases including rheumatoid arthritis, glomerular nephritides, lung fibrosis, restenosis, alveolitis, asthma, psoriasis, inflammatory bowel disease, multiple sclerosis and brain trauma, stroke, ischemia
06/28/2005US6911464 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
06/28/2005US6911463 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity
06/28/2005CA2159071C 4-arylisoindole analgesics
06/28/2005CA2108621C Process for the preparation of mono- or diacetoxyindole
06/23/2005WO2005056693A1 Polymeric dispersant
06/23/2005WO2005056527A1 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
06/23/2005WO2005056013A1 Dpp-iv inhibitors
06/23/2005WO2005014584A9 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis
06/23/2005WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases
06/23/2005WO2004055026A8 Tetracyclic 3-substituted indoles having serotonin receptor affinity
06/23/2005WO2002068380A8 Synthetic excitatory amino acids
06/23/2005US20050137405 Reacting o-chlorobenzaldehyde with an alkyl 4-(phthalimido)ethoxy)acetoacetate to yield alkyl 2-(o-chlorobenzylidene)-4-(2-phthalimidoethoxy)acetoacetate which upon reacting with an alkyl -3-aminocrotonate yields a phtahalimiamlodipine; good yields and purity; useful as reference standards or markers
06/23/2005US20050137246 Organic amine salts of glutamic acid derivatives and their application
06/23/2005US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide
06/23/2005US20050137220 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
06/23/2005US20050137215 Antiarthritic and antiinflammatory agents; analgesics; the proline derivatives do not displace gabapentin from alpha-2-delta receptors
06/23/2005US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels
06/23/2005US20050137168 inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor; for treatment and/or prevention of arterial and venous thrombosis, deep vein thrombosis, pulmonary embolism, unstable angina pectoris, cardiac infarction, stroke
06/23/2005CA2548602A1 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
06/22/2005EP1542973A1 2,4-substituted indoles and their use as 5-ht6 modulators
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005EP1525265A4 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
06/22/2005EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/22/2005EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors
06/22/2005EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme
06/22/2005EP1047672B1 Process for preparing sparingly soluble aromatic amines
06/22/2005CN1630673A Indole resins epoxy resins and resin compositions containing the same
06/22/2005CN1630642A Benzenesulfonamide derivatives
06/22/2005CN1630636A Indoline derivatives and their use as 5-HT2 receptor ligands
06/22/2005CN1630632A Aromatic amino acid derivates and medicinal compositions
06/22/2005CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use
06/22/2005CN1630555A Hydroxylation of beta-dicarbonyls with zirconium catalysts
06/22/2005CN1629140A 3-cyano-1-alkoxy indole derivatives, preparing process and application thereof
06/22/2005CN1207281C Trifluoromethyl-substd. spirocyclic ketoenols
06/21/2005US6909006 Invention provides cyclopropylindole compounds with structures that allow them to be joined to combinatorial chains, as well as combinatorial libraries containing cyclopropylindoles themselves
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005US6908929 Central nervous system disorders
06/21/2005US6908927 Reduction physical cigarette smoking
06/21/2005US6908922 Linear cyclic ureas
06/21/2005CA2382387C Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
06/16/2005WO2005054249A1 Novel compounds
06/16/2005WO2005054195A1 Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives
06/16/2005WO2005054194A1 A method for the preparation of (2s, 3ar, 7as)-octahydro-1h-indole-2-carboxylic acid as key intermediate in the preparation of trandolapril by reacting a cyclohexyl aziridine with a dialkyl malonate
06/16/2005WO2005054193A1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions
06/16/2005WO2005054176A1 Peroxisome proliferator activated receptor modulators
06/16/2005WO2005053686A1 Indolinone based protein kinase inhibitors
06/16/2005WO2005053685A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
06/16/2005WO2005053614A2 Advanced indolinone based protein kinase inhibitors
06/16/2005WO2005053610A2 Diamine and iminodiacetic acid hydroxamic acid derivatives
06/16/2005WO2005040116A3 Indolinone derivatives and their use in treating disease-states such as cancer
06/16/2005WO2005016326A3 Analogs of thalidomide as potential angiogenesis inhibitors
06/16/2005WO2004046107A8 Indole derivatives as somatostatin agonists or antagonists
06/16/2005US20050131237 Indole derivatives
06/16/2005US20050131226 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
06/16/2005US20050131167 Indole resins epoxy resins and resin compositions containing the same
06/16/2005US20050131053 Indole derivatives substituted with long-chain alcolhols and medicaments containing them
06/16/2005US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
06/16/2005US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
06/16/2005US20050131018 Acetylene derivatives as inhibitors of histone deacetylase
06/16/2005US20050130976 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130965 Inhibitors of p38 kinase
06/16/2005US20050130963 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity
06/16/2005US20050130943 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130221 Synthesis for the preparation of compounds for screening as potential tubulin binding agents